IFNG and neoplasm: Continuous stimulation of sgRNA-transduced tumor cells with IFN-γ or TNF allows for the identification of regulatory factors that are sensitive or resistant to these cytokine pathways, based on the survival of the tumor cells [38, 92, 93].